coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Withington & Fallowfield PCN, Manchester (LAD) · Health Inequalities Profile

    PCN U65853 · NHS Greater Manchester Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    48,732

    Registered population

    72.8% aged 18–64

    10.7%

    Aged 65+

    ICB 14.9% · England 17.9%

    38.7%

    Ethnic minority (non-White)

    21.5% Asian · England 9.6%

    31.1%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~13,364

    Core20 residents (est.)

    Resident basis; registered basis ~14,192 · see page 3

    4,897

    Hypertension register

    +5.63% in 3 yrs · England +5.60%

    653

    SMI register

    6.9% of Manchester (LAD)'s

    1,000

    COPD register

    Reviews +2.42% in 3 yrs

    Forecast to 2030

    5,619

    Hypertension patients, 2030

    +722 on today

    73.5%

    QRISK ≥20% on statins, 2030

    +4.72pp over 3 yrs

    2.9%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    55.5%
    Cervical screening in women 25-49 trails England.

    Coverage is 55.5% against 66.8% in England and 57.2% in Manchester (LAD), which may reflect unverified recall or access barriers.

    -0.2%
    Under-80 BP control three-year change lags England.

    Control is 69.7% (England 67.8%), but three-year change was -0.2% against +3.2% in England, which may indicate follow-up gaps.

    75.1%
    Asthma review rate exceeds England and borough.

    Annual reviews reached 75.1% (England 65.7%) and grew +8.9% over three years, though about 750 of 2,999 register patients remain unreviewed.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Working-age adults make up 72.8% of registered patients alongside 38.7% ethnic minority residents

    Across 48,732 registered patients, 72.8% are aged 18–64 (Manchester (LAD) 68.9%, NHS Greater Manchester ICB 63.3%, England 62.7%), while 10.7% are aged 65+ (Manchester (LAD) 9.6%, ICB 14.9%, England 17.9%) and 16.5% are aged 0–17 (Manchester (LAD) 21.4%, ICB 21.8%, England 19.6%). For ethnicity, based on Census usual residents rather than registered patients, 61.3% are White (Manchester (LAD) 56.8%, ICB 76.4%, England 81.1%) and 38.7% ethnic minority, including 21.5% Asian or Asian British (Manchester (LAD) 20.9%, ICB 13.6%, England 9.6%).

    Age profile

    0–1716.5%
    18–6472.8%
    65+10.7%

    65+: ICB 14.9%, England 17.9%

    Ethnicity

    White61.3%
    Asian21.5%
    Black5.9%
    Other5.7%
    Mixed5.7%

    Older people · falls rows are Manchester (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Manchester LA)2,3572,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)82.2%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.8%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Manchester LA)1,2811,0219552024/25
    Falls deaths, all ages, per 100,000 (Manchester LA)26.818.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 share is 31.1% overall, spanning 51.1 percentage points across member practices

    Core20 patients (living in the most deprived 20% of national areas) comprise 31.1% of registered patients, below Manchester (LAD) (59.8%) and NHS Greater Manchester ICB (40.7%), but above England (21.0%). A 2.00 percentage point discrepancy exists against the 29.1% weighted practice share. Deprivation spans 51.1 pp across practices: Ladybarn Group Practice records 51.1% (an estimated 6,202 patients), The Borchardt Medical Centre records 45.9% (an estimated 4,475 patients), and Fallowfield Medical Centre records 0.0%. Outreach should be weighted toward Ladybarn Group Practice and The Borchardt Medical Centre.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Ladybarn51.1% · 6,202 patients
    Borchardt45.9% · 4,475 patients
    Withington17.3% · 893 patients
    Bodey15.4% · 2,413 patients
    Mauldeth6.5% · 209 patients
    Fallowfield0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    653

    SMI register

    1.24% recorded prevalence

    301

    Learning disability register

    0.57% recorded prevalence

    10

    Care homes, 265 beds

    In the PCN catchment

    8.7%

    Provide unpaid care

    Manchester (LAD), Census 2021

    The PCN records 653 patients on the severe mental illness register (prevalence 1.2% versus Manchester (LAD) 1.3%, NHS Greater Manchester ICB 1.1%, England 1.0%) and 301 on the learning disability register (0.6% versus Manchester (LAD) 0.7%, ICB 0.6%, England 0.6%). Catchment data identify 10 care homes with 265 beds.

    Severe mental illness: physical health checks

    Across 653 patients on the severe mental illness register, 81.4% received a blood pressure check (England 83.4%) and 81.4% had BMI recorded (England 82.1%). Incomplete monitoring may leave cardiovascular risk unreviewed, which record audits could test.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    4,897

    Hypertension register

    +5.63%

    Register growth, 3 yrs

    Manchester (LAD) +4.49% · England +5.60%

    −0.15pp

    BP control, under 80

    ≤140/90 · −0.18pp aged 80+

    +722

    More patients by 2030

    Forecast 5,619 (10.36%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 9.3% (4,897 patients), below Manchester (LAD) at 10.5%, NHS Greater Manchester Integrated Care Board at 14.4% and England at 15.2%, though crude rates are unadjusted for age structure and observation periods are unconfirmed. Recent blood pressure checks reach 91.5% (England 90.0%) and under-80 control is 69.7% (England 67.8%). Yet three-year control has stalled: under-80 blood pressure control changed by -0.2% from 2023 to 2025, trailing England (+3.2%). Stalling three-year blood pressure control despite good snapshot attainment may indicate that routine reviews miss active titration, which recall audits could test.

    Lipids and statins

    While 81.2% of diabetes patients without CVD receive statins (England 73.2%), only 62.8% of patients with QRISK ≥ 20% receive lipid-lowering therapy, below Manchester (LAD) at 70.5% and England at 63.6%. Lower therapy uptake in high-risk patients may reflect primary prevention review gaps, which clinical audits could test.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202673,428£2.10£1.94£1.86£154,199
    Cardiovascular (all), 202599,659£2.41£3.15£3.33£240,178

    In 2026, 73,428 lipid-regulating drug items were prescribed at £2.10 per item, below Manchester (LAD) at £2.21 but above England (£1.86), spending £17,623 more than at England's unit cost across those items. Higher unit costs than England could reflect formulation selection across practices, which prescribing audits could test.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +8.92%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.92%

    Asthma prevalence, PCN 3-yr % change

    The PCN records 2,999 asthma patients (prevalence 5.9%, England 6.6%) and 1,000 COPD patients (1.9%, England 1.9%). While annual asthma reviews reached 75.1% (England 65.7%, Manchester (LAD) 67.0%) after rising +8.9% from 2023 to 2025 (England +4.4%), about 750 registered asthma patients lack a recorded review. Asthma prescribing is 1,630 items per 1,000 population aged 5-19 (England 1,488), and COPD reviews stand at 77.3% (England 76.4%). Prioritising outstanding reviews could close unmonitored risk across vulnerable respiratory patients.

    Cancer register and children's immunisation

    Cancer register prevalence is 2.2% across 1,166 patients (England 3.8%). In Q1 2025/26 childhood immunisations, 6-in-1 coverage at 12 months was 83.2% (England 91.0%) and MMR1 at 24 months was 83.6% (England 88.3%), below the 95.0% target. At age 5, MMR dose 1 reached 95.1% whereas dose 2 was 87.8%, a 7.3 pp difference that may reflect recall barriers, which call-recall audits could test.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months83.2%

    England 91.0%

    6-in-1 complete primary course at 24 months93.2%

    England 92.2%

    MMR dose 1 at 24 months83.6%

    England 88.3%

    MMR dose 2 at age 587.8%

    England 82.8%

    4-in-1 pre-school booster at age 582.9%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    Across NHS Greater Manchester ICB in 2022, 55.6% of cancers with a known stage (6,491 of 11,679) were diagnosed at stage 1 or 2, above England (55.3%) but 19.4 pp below the 75.0% national ambition by 2028. This leaves a gap of about 2,270 extra early diagnoses across the ICB, where known-stage coverage was 70.8% (11,679 of 16,492). For the PCN, cervical screening coverage in women aged 25-49 is 55.5%, below Manchester (LAD) (57.2%), NHS Greater Manchester Integrated Care Board (65.9%), and England (66.8%). Practice coverage includes Bodey Medical Centre at 48.5% and Mauldeth Medical Centre at 44.1%.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), Manchester University NHS Foundation Trust achieved 72.8% against the 85.0% cancer 62-day referral to treatment standard, trailing Northern Care Alliance NHS Foundation Trust (78.6%), Stockport NHS Foundation Trust (74.7%) and NHS Greater Manchester Integrated Care Board (75.7%), but above England (71.2%). The trust met the 28-day faster diagnosis standard at 80.1% (75.0% standard; England 79.3%). In July 2026 diagnostics, 11.7% waited 6+ weeks for MRI and 14.7% for CT at Manchester University NHS Foundation Trust, above Northern Care Alliance (5.1% and 4.1%) and Stockport (1.4% and 2.9%). These figures reflect provider activity rather than PCN delivery.

    Pathways within standard (%)ManchesterStockportNorthern Care AllianceGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.0683.2175.2079.5379.32
    31-day treatment (96%)92.5497.3994.5496.4992.50
    62-day referral to treatment (85%)72.8574.6778.6575.7371.16
    Diagnostic waits over 6 weeks (%)ManchesterStockportNorthern Care AllianceEngland
    MRI11.681.415.0921.40
    CT14.662.934.109.92
    Echocardiography4.9117.4631.4828.48
    Colonoscopy4.515.5340.0430.83
    Gastroscopy29.355.3136.4829.02
    All 15 DM01 tests8.9814.0815.7123.14
    Community services activityManchester residentsGreater Manchester ICB
    Care contacts96,995573,310
    Referrals20,27094,470
    Patients with a contact31,040183,535

    Community services (residents of Manchester), Jun 2026 (provisional). In June 2026 (provisional), community health services recorded 96,995 contacts for Manchester borough residents, with 42,015 (43.3%) involving adults aged 65 and over. These figures describe borough resident contacts across community providers rather than PCN-level activity, reflecting broader local system contacts for older residents.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice vaccination achievement spans 67.0 pp alongside a 43.2 pp phone access spread

    In 2025/26, clinical QOF achievement reached 93.3% at Mauldeth Medical Centre and up to 100.0% at Fallowfield Medical Centre (England 97.1%). In contrast, vaccination and immunisation achievement spans 67.0 pp across practices, from 15.6% at Mauldeth Medical Centre to 82.7% at Withington Medical Practice (England 55.2%), showing wide practice variation across the network.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Bodey9515.472.3%70.2%91.8%
    Borchardt9645.959.1%83.6%89.0%
    Withington7217.391.3%78.2%87.8%
    Fallowfield770.092.3%72.1%84.5%
    Ladybarn11351.149.1%70.0%82.6%
    Mauldeth1136.582.3%67.0%81.2%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNManchester (LAD)AssetPCNManchester (LAD)
    Care homes (catchment)10 (265 beds)n/aSchools (catchment)52n/a
    Children's centres334Places of worship33289
    Libraries316Homelessness support (VCS)n/a1
    Primary schools (LA maintained)668Primary academies650
    Special schoolsn/a3

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review recall

    About 750 of 2,999 registered asthma patients lack a recorded review in the last 12 months (75.1% reviewed, above Manchester (LAD) at 67.0% and England at 65.7%). Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Pre-school MMR2 and booster recall

    In Q1 2025/26, age-5 MMR2 is 87.8% versus 95.1% for MMR1 in the same 82-child cohort (7.3 pp lower), and the 4-in-1 booster is 82.9%, below the 95.0% target by 12.1 pp. For discussion, practices could audit age-5 cohorts missing MMR2 or the 4-in-1 booster and offer flexible family appointments. Moderate effort to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 3

    Cervical screening non-responder recall

    Cervical screening coverage in women aged 25-49 is 55.5%, below Manchester (LAD) at 57.2% by 1.7 pp, NHS Greater Manchester ICB at 65.9% by 10.4 pp, and England at 66.8% by 11.3 pp. Moderate effort to run.

    Evidence base: uptake is the delivery measure of the national cancer screening programme; distance to the acceptable and achievable standards is the outreach target.

    Policy anchor: Shift 3: sickness to prevention; Eliminate cervical cancer by 2040.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Culturally adapted cardiovascular outreach (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Weighted Core20 outreach allocation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool MMR booster recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Pre-school MMR2 and booster recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 3 · Cervical screening non-responder recall (p12)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15